Profil
Sam Bakri is the founder of Solascure Ltd., which he founded in 2017 and where he currently holds the title of Executive Chairman.
He is also currently employed as Vice Chairman at Gelmetix Ltd.
Aktive Positionen von Sam Bakri
Unternehmen | Position | Beginn |
---|---|---|
Solascure Ltd.
Solascure Ltd. Medical SpecialtiesHealth Technology Solascure Ltd. operates as a biotech company that develops wound care products. The company was founded by Benjamin Newmark and Sam Bakri in 2017 and is headquartered in Cardiff, the United Kingdom. | Gründer | 01.01.2017 |
Gelmetix Ltd.
Gelmetix Ltd. Miscellaneous Commercial ServicesCommercial Services Gelmetix Ltd. offers a non-surgical procedure for the treatment of chronic lower back pain caused by degenerative disc disease. The firm develops a hydrogel to relieve back pain by enabling cells in the spinal disc to get back to normal functioning, which can be injected into the disc by a healthcare professional and replaces the need for invasive back surgery. The company was founded by Tony Freemont and Brian Saunders in 2012 and is headquartered in Cheshire, the United Kingdom. | Direktor/Vorstandsmitglied | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 2 |
---|---|
Solascure Ltd.
Solascure Ltd. Medical SpecialtiesHealth Technology Solascure Ltd. operates as a biotech company that develops wound care products. The company was founded by Benjamin Newmark and Sam Bakri in 2017 and is headquartered in Cardiff, the United Kingdom. | Health Technology |
Gelmetix Ltd.
Gelmetix Ltd. Miscellaneous Commercial ServicesCommercial Services Gelmetix Ltd. offers a non-surgical procedure for the treatment of chronic lower back pain caused by degenerative disc disease. The firm develops a hydrogel to relieve back pain by enabling cells in the spinal disc to get back to normal functioning, which can be injected into the disc by a healthcare professional and replaces the need for invasive back surgery. The company was founded by Tony Freemont and Brian Saunders in 2012 and is headquartered in Cheshire, the United Kingdom. | Commercial Services |